452P Disease progression site and subsequent therapy after progression during alectinib therapy
نویسندگان
چکیده
منابع مشابه
Rab11 in Disease Progression
Membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases the Rab protein family. Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...
متن کاملPredicting disease progression after regional therapy for in-transit melanoma.
IMPORTANCE Although approximately 30% to 50% of patients experience a complete response after regional chemotherapy for in-transit melanoma, a subset of patients will develop rapidly progressive disease. In the current era of an expanding armamentarium, including both regional and systemic options for treating advanced melanoma, identifying perioperative factors that predict disease progression...
متن کاملEffect of Metacognitive Therapy on Self-efficacy of Pain and Fear of Disease Progression in Nurses with Migraine Headaches
Background & Aim: Feeling of low self-efficacy in management of pain and fear of disease progression are some of the problems that necessitates the need for psychological services for people with migraine headaches. Therefore, this study aimed to determine the effect of metacognitive therapy on the self-efficacy of pain and fear of disease progression in nurses with migraine headaches. Material...
متن کاملrab11 in disease progression
membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. vesicle trafficking in eukaryotes is regulated by a class of small monomeric gtpases the rab protein family. rab proteins represent the largest branch of the ras superfamily gtpases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...
متن کاملABCA4 disease progression and a proposed strategy for gene therapy.
Autosomal recessive retinal diseases caused by mutations in the ABCA4 gene are being considered for gene replacement therapy. All individuals with ABCA4-disease show macular degeneration, but only some are thought to progress to retina-wide blindness. It is currently not predictable if or when specific ABCA4 genotypes will show extramacular disease, and how fast it will progress thereafter. Ear...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2016
ISSN: 0923-7534
DOI: 10.1016/s0923-7534(21)00610-4